Back
Rani Therapeutics Holdings, Inc. 10K Form
Sell
38
RANI
Rani Therapeutics Holdings, Inc.
Last Price:
$1.39
Seasonality Move:
1.43%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RANI News And Ratings
See the #1 stock for the next 7 days that we like better than RANI
RANI Financial Statistics
Sales & Book Value
| Annual Sales: | $1M |
|---|---|
| Cash Flow: | $-5.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.16 |
| Price / Book: | 9.6 |
Profitability
| EPS (TTM): | -0.79070 |
|---|---|
| Net Income (TTM): | $-47.6M |
| Gross Margin: | $0 |
| Return on Equity: | -82920.89% |
| Return on Assets: | -181.21% |
Rani Therapeutics Holdings, Inc. Earnings Forecast
Key Rani Therapeutics Holdings, Inc. Financial Ratios
-
The Gross Profit Margin over the past 6 years for RANI is 0.00%.
-
The Selling, General & Administrative Expenses for RANI have been equal to 2,329.38% of Gross Profit Margin.
-
The Research & Development expenses have been 2,595.53% of Revenue.
-
The Net Earning history of RANI is -5,504.28% of Total Revenues.
-
Per Share Earnings over the last 6 years have been positive in 3 years.
Rani Therapeutics Holdings, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | RANI |
| Website: | ranitherapeutics.com |
Debt
| Debt-to-Equity Ratio: | -2.23 |
|---|---|
| Current Ratio: | 0.26 |
| Quick Ratio: | 0.24 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
RANI Technical Analysis vs Fundamental Analysis
Sell
38
Rani Therapeutics Holdings, Inc. (RANI)
is a Sell
Is Rani Therapeutics Holdings, Inc. a Buy or a Sell?
-
Rani Therapeutics Holdings, Inc. stock is rated a SellThe current Rani Therapeutics Holdings, Inc. [RANI] share price is $1.40. The Score for RANI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.